Oakworth Capital’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$59.9K Hold
663
﹤0.01% 423
2025
Q4
$59.6K Sell
663
-16
-2% -$1.52K ﹤0.01% 412
2025
Q3
$66.9K Buy
679
+439
+183% +$43.5K ﹤0.01% 406
2025
Q2
$21.9K Buy
240
+40
+20% +$3.87K ﹤0.01% 436
2025
Q1
$22.6K Hold
200
﹤0.01% 443
2024
Q4
$21.1K Sell
200
-178
-47% -$19.1K ﹤0.01% 454
2024
Q3
$40.8K Hold
378
﹤0.01% 378
2024
Q2
$41K Buy
378
+78
+26% +$9.2K ﹤0.01% 362
2024
Q1
$39.6K Hold
300
﹤0.01% 342
2023
Q4
$36.5K Sell
300
-9
-3% -$1K ﹤0.01% 356
2023
Q3
$34.7K Sell
309
-8
-3% -$1.02K ﹤0.01% 339
2023
Q2
$46.2K Sell
317
-1
-0.3% -$136 ﹤0.01% 315
2023
Q1
$41.1K Hold
318
﹤0.01% 318
2022
Q4
$40.5K Buy
318
+68
+27% +$7.89K ﹤0.01% 303
2022
Q3
$26K Hold
250
﹤0.01% 364
2022
Q2
$26K Hold
250
﹤0.01% 364
2022
Q1
$32K Sell
250
-8
-3% -$964 ﹤0.01% 346
2021
Q4
$32K Sell
258
-51
-17% -$6.67K ﹤0.01% 374
2021
Q3
$44K Sell
309
-82
-21% -$12.1K ﹤0.01% 327
2021
Q2
$61K Sell
391
-30
-7% -$4.86K 0.01% 292
2021
Q1
$65K Buy
421
+22
+6% +$3.41K 0.01% 284
2020
Q4
$60K Hold
399
0.01% 264
2020
Q3
$53K Hold
399
0.01% 264
2020
Q2
$46K Hold
399
0.01% 282
2020
Q1
$39K Hold
399
0.01% 269
2019
Q4
$58K Hold
399
0.01% 276
2019
Q3
$53K Sell
399
-292
-42% -$37.7K 0.01% 282
2019
Q2
$79K Buy
691
+272
+65% +$31.9K 0.02% 266
2019
Q1
$52K Hold
419
0.01% 301
2018
Q4
$42K Hold
419
0.01% 310
2018
Q3
$54K Hold
419
0.01% 289
2018
Q2
$45K Hold
419
0.01% 314
2018
Q1
$47K Hold
419
0.01% 290
2017
Q4
$48K Hold
419
0.01% 295
2017
Q3
$47K Hold
419
0.01% 302
2017
Q2
$52K Hold
419
0.01% 284
2017
Q1
$50K Hold
419
0.01% 278
2016
Q4
$41K Buy
419
+103
+33% +$11K 0.01% 286
2016
Q3
$40K Hold
316
0.01% 281
2016
Q2
$37K Hold
316
0.01% 285
2016
Q1
$33K Hold
316
0.01% 251
2015
Q4
$31K Buy
316
+309
+4,414% +$30.2K 0.01% 237
2015
Q3
$1K Hold
7
﹤0.01% 450
2015
Q2
$1K Hold
7
﹤0.01% 456
2015
Q1
$1K Hold
7
﹤0.01% 467
2014
Q4
$1K Buy
+7
New +$738 ﹤0.01% 457

Other funds holding ZBH

Oakworth Capital's ZBH Position: Q1 2026 in Review

Oakworth Capital held its Zimmer Biomet (ZBH) position steady in Q1 2026 at 663 shares worth $59.9K. The position accounts for ﹤0.01% of the portfolio, ranked #423.

Oakworth Capital first reported a position in ZBH in Q4 2014 and has held it in 46 quarters since. The position peaked at $79K in Q2 2019. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Oakworth Capital held 663 shares of Zimmer Biomet worth $59.9K as of Q1 2026.
  • Oakworth Capital left its Zimmer Biomet share count unchanged in Q1 2026.
  • Zimmer Biomet made up ﹤0.01% of Oakworth Capital's portfolio in Q1 2026, its #423 holding.
  • Oakworth Capital first reported a position in Zimmer Biomet in Q4 2014 and has held it in 46 quarters since.
  • Oakworth Capital's Zimmer Biomet position peaked at $79K in Q2 2019.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Oakworth Capital's 13F filing for Q1 2026, filed 24 Apr 2026.